About
Febuxostat is a potent, non-purine selective inhibitor of xanthine oxidase, an enzyme crucial for uric acid synthesis. It is primarily indicated for the chronic management of hyperuricemia in adult patients with gout, a condition characterized by elevated uric acid levels leading to crystal deposition in joints and tissues. By effectively reducing the production of uric acid, febuxostat helps to lower serum uric acid concentrations, thereby preventing the formation of new urate crystals and dissolving existing ones. This action significantly reduces the frequency and severity of gout flares and mitigates the risk of long-term joint damage and kidney stone formation. Treatment with febuxostat is typically initiated after an acute gout attack has resolved, as starting during a flare can transiently exacerbate symptoms. Consistent adherence to the prescribed regimen and regular monitoring of uric acid levels are vital for optimal therapeutic outcomes and to ensure the medication's long-term efficacy in managing this chronic condition.
Uses
- Chronic management of hyperuricemia.
- Prevention of gout flares.
- Reduction of serum uric acid levels.
- Dissolution of urate crystals.
Directions For Use
Take one tablet orally once daily, with or without food, as directed by your physician. Do not crush or chew the tablet.
Benefits
- Effectively lowers serum uric acid.
- Reduces the incidence of gout attacks.
- Helps prevent joint damage.
- Offers a convenient once-daily dose.
- Can be taken independently of meals.
- Provides long-term disease management.
Side Effects
- Nausea
- Diarrhea
- Headache
- Liver function abnormalities
- Rash
- Joint pain
- Dizziness
- Muscle pain
- Swelling
- Chest pain
- Palpitations
- Initial gout flares
Safety Measures
- Alcohol - Alcohol, particularly beer and spirits, can elevate uric acid levels and may diminish febuxostat's effectiveness. Limit or avoid alcohol consumption.
- Pregnancy - Febuxostat is generally not recommended during pregnancy due to limited human data. Consult your doctor for safer alternatives.
- Breastfeeding - It is unknown if febuxostat passes into breast milk. A decision to discontinue nursing or the drug should be made, considering the mother's need for the medication.
- Liver - Use with caution in patients with mild to moderate hepatic impairment. Regular monitoring of liver function tests is advised. Severe impairment is a contraindication.
- Kidney - Dose adjustment may be necessary for patients with severe renal impairment. Use with caution and monitor kidney function closely.
- Lung - No specific contraindications or dose adjustments are typically required for patients with pre-existing lung conditions.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!